ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GA20182-005mg |
|
144410-00-4 |
(Gln²²)-Amyloid β-Protein (1-40)
|
0 | C194H296N54O57S | |
GA20181-1mg |
|
106686-61-7 |
(Gln¹¹)-Amyloid β-Protein (1-28)
|
0 | C145H210N42O45 | |
GA20181-005mg |
|
106686-61-7 |
(Gln¹¹)-Amyloid β-Protein (1-28)
|
0 | C145H210N42O45 | |
GA20180-25mg |
|
145082-23-1 |
(Fmoc-Glu⁷⁰,Ala⁷¹·⁷²,Lys⁷⁴)-C3a (70-77)
|
0 | C53H80N12O13 | |
GA20180-5mg |
|
145082-23-1 |
(Fmoc-Glu⁷⁰,Ala⁷¹·⁷²,Lys⁷⁴)-C3a (70-77)
|
0 | C53H80N12O13 | |
GA20179-5g |
|
139592-37-3 |
(Fmoc-Cys-OtBu)₂
|
0 | C44H48N2O8S2 | |
GA20179-1g |
|
139592-37-3 |
(Fmoc-Cys-OtBu)₂
|
0 | C44H48N2O8S2 | |
GA20178-5g |
|
112514-60-0 |
(Fmoc-Cys-OSu)₂
|
0 | C44H38N4O12S2 | |
GA20178-1g |
|
112514-60-0 |
(Fmoc-Cys-OSu)₂
|
0 | C44H38N4O12S2 | |
GA20177-25g |
|
135273-01-7 |
(Fmoc-Cys-OH)₂
|
0 | C36H32N2O8S2 | |
GA20177-5g |
|
135273-01-7 |
(Fmoc-Cys-OH)₂
|
0 | C36H32N2O8S2 | |
GA20177-1g |
|
135273-01-7 |
(Fmoc-Cys-OH)₂
|
0 | C36H32N2O8S2 | |
GA20176-5mg |
|
1053627-10-3 |
(D-Tyr⁶,βPhe¹¹,Phe¹³,Nle¹⁴)-Bombesin (6-14) (free acid)
|
0 | C63H79N13O12 | |
GA20176-1mg |
|
1053627-10-3 |
(D-Tyr⁶,βPhe¹¹,Phe¹³,Nle¹⁴)-Bombesin (6-14) (free acid)
|
0 | C63H79N13O12 | |
GA20175-5mg |
|
321709-35-7 |
(D-Tyr⁵,D-Trp⁶)-LHRH
|
0 | C64H82N18O13 | |
GA20175-1mg |
|
321709-35-7 |
(D-Tyr⁵,D-Trp⁶)-LHRH
|
0 | C64H82N18O13 | |
GA20174-5mg |
|
1426173-74-1 |
(D-Tyr⁵,D-Ser(tBu)⁶,Azagly¹⁰)-LHRH
|
0 | C59H84N18O14 | |
GA20174-1mg |
|
1426173-74-1 |
(D-Tyr⁵,D-Ser(tBu)⁶,Azagly¹⁰)-LHRH
|
0 | C59H84N18O14 | |
GA20173-25mg |
|
64088-62-6 |
(D-Tyr¹¹)-Neurotensin
|
0 | C78H121N21O20 | |
GA20173-5mg |
|
64088-62-6 |
(D-Tyr¹¹)-Neurotensin
|
0 | C78H121N21O20 | |